Institutional Fund
Andera Partners
Paris, FranceCIK 17572832 filings on record
Portfolio Value
$176.92M
Q1 2026
Holdings
7
Reported positions
New Buys
2
Opened this quarter
QoQ Change
+0.2%
from $176.61M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Kestra Med Technologies Ltd30.4%
- Evommune Inc24.7%
- Mineralys Therapeutics Inc24.4%
- Agomab Therapeutics NV9.1%
- Inventiva SA5.7%
- Abivax SA4.9%
- Other0.9%
Portfolio Holdings
7 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Kestra Med Technologies Ltd | 2.70M | $53.72M | 30.4% | +155.1K | Added |
| 2 | Evommune Inc | 1.90M | $43.62M | 24.7% | 0 | Held |
| 3 | Mineralys Therapeutics Inc | 1.59M | $43.13M | 24.4% | 0 | Held |
| 4 | Agomab Therapeutics NV | 1.54M | $16.14M | 9.1% | +1.54M | New |
| 5 | Inventiva SA | 1.82M | $10.09M | 5.7% | 0 | Held |
| 6 | Abivax SA | 78.1K | $8.70M | 4.9% | 0 | Held |
| 7 | Nyxoah S A | 522.1K | $1.52M | 0.9% | +522.1K | New |